Predictors of ICU Admission and In-Hospital Mortality in Hospitalized Patients With Lupus Nephritis: The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and C Reactive Protein to Serum Albumin Ratio
NCT07783711 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2026-08-26
Summary
To identify clinical and laboratory predictors of ICU admission and in-hospital mortality among hospitalized adults with lupus nephritis by evaluating the prognostic performance of NLR and CAR, comparing them with CRP and albumin using ROC analysis, determining optimal cutoff values, and identifying independent predictors through multivariable logistic regression
Conditions
- Lupus Nephritis (LN)
Sponsors & Collaborators
-
Assiut University
collaborator OTHER -
Khaled Samir Malak Nashed
lead OTHER
Principal Investigators
-
Samir Kamal · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-30
- Primary Completion
- 2028-09-01
- Completion
- 2028-10-01
More Related Trials
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
Neutrophil Extracellular Traps and Lupus Nephritis
NCT07721857 ·Status: NOT_YET_RECRUITING
-
Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis
NCT03958851 ·Status: UNKNOWN
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis
NCT06872138 ·Status: COMPLETED
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
Urinary G3BP as a Novel Biomarker in Lupus Nephritis
NCT06520670 ·Status: NOT_YET_RECRUITING
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Drug Therapy in Lupus Nephropathy
NCT00001212 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital
NCT05120882 ·Status: UNKNOWN
-
Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit
NCT05418855 ·Status: UNKNOWN
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population
NCT07700940 ·Status: RECRUITING ·Phase: PHASE4
-
Lupus Nephritis Care Pathway
NCT07783152 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
NCT07017868 ·Status: RECRUITING
-
Urinary Congophilia As an Indicator of Activity of Lupus Nephritis
NCT06654024 ·Status: NOT_YET_RECRUITING
-
Predictors of Bone Mineral Density in Lupus Nephritis Activity
NCT06837558 ·Status: NOT_YET_RECRUITING
-
Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation
NCT04870359 ·Status: COMPLETED ·Phase: NA
-
Prediction of Lupus Renal Flares Study
NCT05362812 ·Status: UNKNOWN
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital
NCT04756492 ·Status: UNKNOWN
-
Identifying New Therapeutic Targets for Lupus Treatment
NCT03921398 ·Status: COMPLETED
-
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183 ·Status: COMPLETED
-
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
NCT05126277 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3